逍遥散治疗经前期综合征69例

逍遥散出自《太平惠民和剂局方》，由当归、白芍药、柴胡、茯苓、白术、炙甘草、薄荷、煨姜组成。经前期综合征为临床常见的妇科病症，笔者近年来采用逍遥散加减治疗经前期综合征69例，疗效满意，现报道如下。     

脑梗塞合并精神障碍病人的分型及护理

脑梗塞是由于脑动脉粥样硬化和血栓形成使管腔闭塞，导致急性脑供血不足和脑组织局部坏死的临床症候群。其主要临床表现为偏瘫和失语。其中部分病人还可合并精神障碍。脑梗塞在我国十分常见，据文献报道：我国每年约有150余万人发生脑梗塞，因此认为做好脑梗塞病人的治疗和护理，尽快恢复其肢体和脑功能，具有十分重要的临床意义和社会意义。     

Ruptured distal anterior choroidal artery aneurysm.

Ruptured aneurysms of the distal anterior choroidal artery (AchA) are extremely rare and management is dictated by clinical presentation. This report describes a rare patient with a distal AchA aneurysm and subarachnoid and intraventricular haemorrhage. A 60-year-old woman presented with a sudden onset of severe headache and vomiting. No aneurysms could be found on initial angiograms. A repeat angiogram performed 10 days after admission demonstrated an aneurysm in a branch of the cisternal segment of the left AchA without a definite neck. Surrounding vessels showed multifocal stricture and dilatation. Microsurgical clipping was not performed because the patient died suddenly due to pulmonary failure. The aetiology of the aneurysm in this case and surgical strategy are discussed.     

危重症患者的APACHEⅡ评分与中医辨证相关性研究

目的：通过比较不同中医证型的ICU危重症患者的APACHEⅡ评分，同时对比两组死亡率，评价中医辨证在预后判断中的临床意义。方法：对纳入研究的85例ICU危重症患者于入ICU及出ICU时分别进行中医辨证，分为阳类证和阴类证两型，对所有病人进行APACHEⅡ评分，比较两型病人在进入ICU及出ICU时的APACHEⅡ分值，并与死亡率比较。结果：初始为阴类证的患者在入ICU及出ICU时的APACHEⅡ评分显著高于初始为阳类证的患者（P=0．0001及F〈0．05），死亡率亦显著高于阳类证患者（P=0．0369）：治疗后由阳类证转为阴类证患者APACHEⅡ评分较维持阳类证者增高（P=0．0161），而阴类证转为阳类证的患者APACHEⅡ分值较维持阴类证者减低（P=0．0424）。结论：中医证型对危重症的病情程度及预后判断有较好的预测价值，阴类证患者的预后较阳类证患者差，证型转换可能引起预后改变。     

Cause-specific and total mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population: a 15-year follow-up study.

AIMS: To establish all-cause and cause-specific death rates, and risk factors for mortality in insulin-treated diabetic individuals living in the province of Canterbury, New Zealand. METHODS: Insulin-treated diabetic subjects (n = 995) on the Canterbury Diabetes Registry were followed up over 15 years and vital status determined. Death rates were standardized and hazard regression was used to model the effects of demographic covariates on relative survival time. RESULTS: There were 419 deaths in 11 226.3 person-years of follow-up with a standardized mortality ratio (SMR) of 2.0 (95% confidence interval (CI) 1.8-2.2). Relative mortality was greatest for the group aged 0-29 years (SMR 3.0 (95% CI 2.4-3.7)). After controlling for diabetes duration and gender, a 10-year increment in age of onset was associated with a 33% decrease in relative hazard (95% CI 29-36%), indicating that excess mortality due to diabetes declines with rising age of onset. After controlling for age of onset and gender, each 10-year increment in duration of diabetes is associated with a 26% decrease in relative hazard (95% CI 24-29%), indicating that with longer survival the mortality hazard approaches the general population hazard. Relative mortalities were increased for cardiovascular, renal and respiratory disease, but not malignancy. Relative mortality from acute metabolic complications was increased in the subgroup with age of onset of diabetes < 30 years and requiring insulin within 1 year of diagnosis. CONCLUSIONS: Mortality rates are high for insulin-treated diabetic individuals relative to the general population.     

国产COSTANT冠状动脉支架治疗重症冠心病的远期疗效观察

目的评价国产COSTANT冠脉支架治疗重症冠心病的安全性和远期疗效。方法回顾性分析2001-03～2003-08沈阳军区总医院和广州省人民医院2个心脏中心应用COSTANT冠脉支架治疗71例重症冠心病者即刻疗效和2年随访结果。结果共置入COSTANT支架86枚，其他支架58枚，手术成功率均为100％。院内主要不良心脏事件（MACE）共3例（其中死亡2例、1例支架内发生亚急性血栓）。69例失访6例（随访率91．3％），63例随访21～26个月中4例死亡，21例行冠脉造影复查（占30．4％），8例发生再狭窄（RS）（COSTANT支架4例，其他支架3例，1例COSTANT和其他支架均RS并死亡），5例出现新生病变。COSTANT支架RS率为7．9％（5／63）、MACE发生率12．7％（8／63）。结论2年的长期随访结果表明国产COSTANT冠状动脉支架可安全用于重症冠心病介入治疗，且长期疗效较好。     

Tacrolimus Combined with Two Different Dosages of Sirolimus in Kidney Transplantation: Results of a Multicenter Study

Tacrolimus combined with mycophenolate mofetil (MMF) is an effective regimen in kidney transplantation. This study compared the efficacy of combining tacrolimus and two different dosages of sirolimus with an established tacrolimus-MMF regimen. Each day in addition to tacrolimus, 325 patients received 2 mg sirolimus (TAC-SRL2 mg), 325 patients received 0.5 mg sirolimus (TAC-SRL0.5 mg) and 327 patients 1 g MMF (TAC-MMF). The initial tacrolimus dose was 0.2 mg/kg/day. Sirolimus patients received loading doses of 6 or 1.5 mg, and daily doses of 2 or 0.5 mg thereafter. Steroid administration was identical for all groups. The incidence of biopsy-proven acute rejection was lower in the TAC-SRL2 mg group (15.7%) compared with the TAC-SRL0.5 mg (25.2%, p = 0.003) and the TAC-MMF groups (22.3%, p = 0.036). Six-month graft survival was 91.0% (TAC-SRL2 mg), 92.6% (TAC-SRL0.5 mg) and 92.4% (TAC-MMF); the respective values for patient survival were 98.1%, 97.8% and 97.9%. Thirty-four patients (10.5%), 19 patients (5.8%) and 16 patients (4.9%) in the TAC-SRL2 mg, TAC-SRL0.5 mg and TAC-MMF groups, respectively, discontinued the study because of adverse events. Hyperlipemia was reported more often in the TAC-SRL2 mg group (24.0%) compared with 19.4% (TAC-SRL0.5 mg) and 11.0% (TAC-MMF; p < 0.05). Combining 2 mg sirolimus/day with tacrolimus results in lower rates of acute rejection, but a higher incidence of adverse events.     

体外诱导条件下大鼠骨髓基质细胞骨钙素和Ⅰ型胶原mRNA的表达

目的　研究体外培养大鼠骨髓基质细胞诱导条件下 ,成骨分化标志骨钙素和 型胶原 m RNA水平的表达。方法　采用成骨诱导剂 (含地塞米松 10 - 8mol/ L、β甘油磷酸钠 10 mm ol/ L和抗坏血酸 AA 5 0μg/ml)对培养状态下的不同代大鼠骨髓基质细胞进行成骨诱导 ,提取 RNA,采用 RT- PCR方法 ,以β-肌动蛋白 c DNA为内参照 ,检测骨钙素和 型胶原 m RNA的表达。结果　与对照组相比 ,接受成骨诱导剂作用的大鼠骨髓基质细胞随诱导时间的延长骨钙素和 型胶原 m RNA出现高表达 ,且维生素 D为诱导骨钙素 m RNA表达的必需成分。结论　体外培养的大鼠骨髓基质细胞保持成骨未分化状态 ,无骨钙素和 型胶原 m RNA的表达 ,诱导后可向成骨分化 ,骨钙素和 型胶原 m RNA表达升高